Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography (CAPITAL-PRO)
Primary Purpose
Embolism and Thrombosis of the Radial Artery, Coronary Heart Disease
Status
Completed
Phase
Not Applicable
Locations
Canada
Study Type
Interventional
Intervention
Glidesheath Slender
standard 6- French radial sheath
Sponsored by
About this trial
This is an interventional prevention trial for Embolism and Thrombosis of the Radial Artery focused on measuring transradial coronary angiography, radial artery occlusion, coronary heart disease, Glidesheath Slender
Eligibility Criteria
Inclusion Criteria:
- Patients undergoing coronary angiography and/or PCI via transradial approach
- Informed consent
- Documented normal Allen's test
Exclusion Criteria:
- Patient who had a previous angiogram using the same radial artery
- Abnormal Allen's test
- Previous failed radial access.
- Known bleeding disorder or hypercoagulable condition
- Cardiogenic shock
Sites / Locations
- University of Ottawa Heart Institute
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Glidesheath Slender
Standard sheath
Arm Description
The transradial procedure will be performed using the glidesheath slender (studied sheath)
The transradial procedure will be performed using the standard 6- French radial sheath (comparator sheath)
Outcomes
Primary Outcome Measures
Radial artery occlusion
Evaluated clinically and by ultrasound
Secondary Outcome Measures
Vascular access site complications
Includes: Radial artery occlusion, bleeding or hematoma, pseudoaneurysm, artery dissection, compartment syndrome of the forearm
Radial artery spasm
Procedure success
Defined as ability to finish the angiogram/PCI via the intended access site, without the need to change access site.
Sheath kinking
Major requiring sheath exchange or minor
Painful sheath removal
Scored on a scale of 1-10 scoring system
Full Information
NCT ID
NCT02324764
First Posted
December 8, 2014
Last Updated
January 27, 2022
Sponsor
Ottawa Heart Institute Research Corporation
1. Study Identification
Unique Protocol Identification Number
NCT02324764
Brief Title
Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Acronym
CAPITAL-PRO
Official Title
Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Completed
Study Start Date
December 2014 (undefined)
Primary Completion Date
March 2019 (Actual)
Study Completion Date
March 21, 2019 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ottawa Heart Institute Research Corporation
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The objective of this study is to determine the rate of radial artery occlusion and vascular access site complications following transradial angiogram using a new Terumo (Tokyo, Japan) Glidesheath Slender, in comparison with the currently used 6 French (6 Fr.) radial sheath.
Detailed Description
Based on previously reported studies the rates of radial artery occlusion using a standard 6 Fr. sheath is around 5-10%, compared to the single feasibility study of the Glidesheath Slender by Aminian et al (see reference in the citations), the rate of radial artery occlusion was reported 0.88%.
This study will be a prospective randomized, single-blinded (patient-blinded) study, comparing the rate of radial artery occlusion and vascular access site complications between the Glidesheath Slender (Terumo, Tokyo, Japan) and the standard 6 Fr. radial sheath in patients undergoing transradial coronary catheterization.
The study will enroll patients who will undergo elective or emergency coronary angiography and/or percutaneous coronary intervention (PCI) via transradial approach at the University of Ottawa Heart Institute.
A baseline clinical vascular & ultrasound assessment will be performed prior to the procedure to document patency of the radial artery.
Patients will be randomized in 1:1 fashion to either receive the Terumo Glidesheath Slender versus the currently used 6 Fr. sheath.
The standard angiogram/ PCI will be performed as per usual practice.
Following the angiogram, clinical vascular assessment as well as an ultrasound will be performed prior to discharge.
At 30 days follow up the patient will come back for clinical and ultrasound assessment of radial artery patency and access site vascular complications.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Embolism and Thrombosis of the Radial Artery, Coronary Heart Disease
Keywords
transradial coronary angiography, radial artery occlusion, coronary heart disease, Glidesheath Slender
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
400 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Glidesheath Slender
Arm Type
Experimental
Arm Description
The transradial procedure will be performed using the glidesheath slender (studied sheath)
Arm Title
Standard sheath
Arm Type
Active Comparator
Arm Description
The transradial procedure will be performed using the standard 6- French radial sheath (comparator sheath)
Intervention Type
Device
Intervention Name(s)
Glidesheath Slender
Other Intervention Name(s)
Glidesheath Slender, Terumo, Tokyo, Japan
Intervention Description
testing the efficacy and safety of the new transradial sheath in comparison to the standard 6 french sheath.
Intervention Type
Device
Intervention Name(s)
standard 6- French radial sheath
Primary Outcome Measure Information:
Title
Radial artery occlusion
Description
Evaluated clinically and by ultrasound
Time Frame
30 days
Secondary Outcome Measure Information:
Title
Vascular access site complications
Description
Includes: Radial artery occlusion, bleeding or hematoma, pseudoaneurysm, artery dissection, compartment syndrome of the forearm
Time Frame
up to 30 days
Title
Radial artery spasm
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 1 day
Title
Procedure success
Description
Defined as ability to finish the angiogram/PCI via the intended access site, without the need to change access site.
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 1 day
Title
Sheath kinking
Description
Major requiring sheath exchange or minor
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 1 day
Title
Painful sheath removal
Description
Scored on a scale of 1-10 scoring system
Time Frame
participants will be followed for the duration of hospital stay, an expected average of 1 day
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients undergoing coronary angiography and/or PCI via transradial approach
Informed consent
Documented normal Allen's test
Exclusion Criteria:
Patient who had a previous angiogram using the same radial artery
Abnormal Allen's test
Previous failed radial access.
Known bleeding disorder or hypercoagulable condition
Cardiogenic shock
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Aun-Yeong Chong, MRCP, MD
Organizational Affiliation
University of Ottawa Heart Institute Research Corporation
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Ottawa Heart Institute
City
Ottawa
State/Province
Ontario
ZIP/Postal Code
K1Y 4W7
Country
Canada
12. IPD Sharing Statement
Citations:
PubMed Identifier
24461923
Citation
Kotowycz MA, Johnston KW, Ivanov J, Asif N, Almoghairi AM, Choudhury A, Nagy CD, Sibbald M, Chan W, Seidelin PH, Barolet AW, Overgaard CB, Dzavik V. Predictors of radial artery size in patients undergoing cardiac catheterization: insights from the Good Radial Artery Size Prediction (GRASP) study. Can J Cardiol. 2014 Feb;30(2):211-6. doi: 10.1016/j.cjca.2013.11.021. Epub 2013 Nov 23.
Results Reference
background
PubMed Identifier
24285594
Citation
Aminian A, Dolatabadi D, Lefebvre P, Zimmerman R, Brunner P, Michalakis G, Lalmand J. Initial experience with the Glidesheath Slender for transradial coronary angiography and intervention: a feasibility study with prospective radial ultrasound follow-up. Catheter Cardiovasc Interv. 2014 Sep 1;84(3):436-42. doi: 10.1002/ccd.25232. Epub 2013 Nov 6.
Results Reference
background
PubMed Identifier
22338002
Citation
Kotowycz MA, Dzavik V. Radial artery patency after transradial catheterization. Circ Cardiovasc Interv. 2012 Feb 1;5(1):127-33. doi: 10.1161/CIRCINTERVENTIONS.111.965871. No abstract available.
Results Reference
background
Learn more about this trial
Use of Glidesheath Slender to Reduce Radial Artery Occlusion and Vascular Access Site Complications Following Transradial Coronary Angiography
We'll reach out to this number within 24 hrs